The 2016-2021 World Outlook for Ophthalmic Pharmaceutical Drugs

 Published On: Apr, 2015 |    No of Pages: 245 |  Published By: Icon Group International, Inc | Format: PDF
Request Free Sample

This econometric study covers the world outlook for ophthalmic pharmaceutical drugs across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved.

This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the 230 countries of the world).

This study gives, however, my estimates for the worldwide latent demand, or the P.I.E., for ophthalmic pharmaceutical drugs. It also shows how the P.I.E. is divided across the world’s regional and national markets. For each country, I also show my estimates of how the P.I.E. grows over time (positive or negative growth). In order to make these estimates, a multi-stage methodology was employed that is often taught in courses on international strategic planning at graduate schools of business.

Table Of Contents:

1 INTRODUCTION 10
1.1 Overview 10
1.2 What is Latent Demand and the P.I.E.? 10
1.3 The Methodology 11
1.3.1 Step 1. Product Definition and Data Collection 12
1.3.2 Step 2. Filtering and Smoothing 13
1.3.3 Step 3. Filling in Missing Values 13
1.3.4 Step 4. Varying Parameter, Non-linear Estimation 13
1.3.5 Step 5. Fixed-Parameter Linear Estimation 14
1.3.6 Step 6. Aggregation and Benchmarking 14
1.3.7 Step 7. Latent Demand Density: Allocating Across Cities 14
1.4 Frequently Asked Questions (FAQ) 15
1.4.1 Category Definition 15
1.4.2 Units 15
1.4.3 Methodology 16
2 SUMMARY OF FINDINGS 18
2.1 The Worldwide Market Potential 18
3 AFRICA 20
3.1 Executive Summary 20
3.2 Algeria 22
3.3 Angola 24
3.4 Benin 24
3.5 Botswana 25
3.6 Burkina Faso 26
3.7 Burundi 27
3.8 Cameroon 28
3.9 Cape Verde 29
3.10 Central African Republic 29
3.11 Chad 30
3.12 Comoros 31
3.13 Congo (formerly Zaire) 32
3.14 Cote d'Ivoire 33
3.15 Djibouti 33
3.16 Egypt 34
3.17 Equatorial Guinea 35
3.18 Eritrea 36
3.19 Ethiopia 37
3.20 Gabon 38
3.21 Ghana 38
3.22 Guinea 40
3.23 Guinea-Bissau 40
3.24 Kenya 41
3.25 Lesotho 43
3.26 Liberia 44
3.27 Libya 44
3.28 Madagascar 45
3.29 Malawi 46
3.30 Mali 46
3.31 Mauritania 47
3.32 Mauritius 48
3.33 Morocco 48
3.34 Mozambique 49
3.35 Namibia 50
3.36 Niger 51
3.37 Nigeria 52
3.38 North Sudan 54
3.39 Republic of Congo 55
3.40 Rwanda 56
3.41 Sao Tome E Principe 56
3.42 Senegal 57
3.43 Sierra Leone 58
3.44 Somalia 58
3.45 South Africa 59
3.46 South Sudan 60
3.47 Swaziland 61
3.48 Tanzania 61
3.49 The Gambia 62
3.50 Togo 63
3.51 Tunisia 64
3.52 Uganda 65
3.53 Western Sahara 66
3.54 Zambia 66
3.55 Zimbabwe 67
4 ASIA & THE MIDDLE EAST 69
4.1 Executive Summary 69
4.2 Afghanistan 71
4.3 Armenia 72
4.4 Azerbaijan 73
4.5 Bahrain 74
4.6 Bangladesh 74
4.7 Bhutan 76
4.8 Brunei 76
4.9 Burma 77
4.10 Cambodia 78
4.11 China 78
4.12 Hong Kong 80
4.13 India 81
4.14 Indonesia 83
4.15 Iran 85
4.16 Iraq 88
4.17 Israel 89
4.18 Japan 90
4.19 Jordan 93
4.20 Kuwait 94
4.21 Kyrgyzstan 95
4.22 Laos 96
4.23 Lebanon 97
4.24 Macau 97
4.25 Malaysia 98
4.26 Maldives 99
4.27 Mongolia 100
4.28 Nepal 101
4.29 North Korea 102
4.30 Oman 103
4.31 Pakistan 103
4.32 Palestine 105
4.33 Papua New Guinea 106
4.34 Philippines 107
4.35 Qatar 111
4.36 Saudi Arabia 112
4.37 Seychelles 113
4.38 Singapore 113
4.39 South Korea 114
4.40 Sri Lanka 116
4.41 Syrian Arab Republic 116
4.42 Taiwan 118
4.43 Tajikistan 119
4.44 Thailand 119
4.45 The United Arab Emirates 120
4.46 Timor - Leste, Democratic Republic of 121
4.47 Turkey 121
4.48 Turkmenistan 124
4.49 Uzbekistan 125
4.50 Vietnam 126
4.51 Yemen 127
5 EUROPE 128
5.1 Executive Summary 128
5.2 Albania 130
5.3 Andorra 131
5.4 Austria 131
5.5 Belarus 132
5.6 Belgium 133
5.7 Bosnia and Herzegovina 134
5.8 Bulgaria 135
5.9 Croatia 136
5.10 Cyprus 136
5.11 Czech Republic 137
5.12 Denmark 138
5.13 Estonia 139
5.14 Finland 140
5.15 France 141
5.16 Georgia 143
5.17 Germany 143
5.18 Greece 144
5.19 Hungary 146
5.20 Iceland 147
5.21 Ireland 148
5.22 Italy 148
5.23 Kazakhstan 150
5.24 Kosovo 152
5.25 Latvia 152
5.26 Liechtenstein 153
5.27 Lithuania 154
5.28 Luxembourg 154
5.29 Macedonia 155
5.30 Malta 156
5.31 Moldova 156
5.32 Monaco 157
5.33 Montenegro 158
5.34 Norway 158
5.35 Poland 159
5.36 Portugal 161
5.37 Romania 162
5.38 Russia 163
5.39 San Marino 166
5.40 Serbia 166
5.41 Slovakia 167
5.42 Slovenia 168
5.43 Spain 169
5.44 Sweden 171
5.45 Switzerland 172
5.46 The Netherlands 173
5.47 The United Kingdom 175
5.48 Ukraine 177
6 LATIN AMERICA 180
6.1 Executive Summary 180
6.2 Argentina 182
6.3 Belize 185
6.4 Bolivia 186
6.5 Brazil 187
6.6 Chile 190
6.7 Colombia 191
6.8 Costa Rica 193
6.9 Ecuador 194
6.10 El Salvador 195
6.11 Guatemala 196
6.12 Guyana 197
6.13 Honduras 197
6.14 Mexico 198
6.15 Nicaragua 200
6.16 Panama 201
6.17 Paraguay 201
6.18 Peru 202
6.19 Suriname 203
6.20 The Falkland Islands 204
6.21 Uruguay 205
6.22 Venezuela 206
7 NORTH AMERICA & THE CARIBBEAN 208
7.1 Executive Summary 208
7.2 Antigua and Barbuda 209
7.3 Aruba 210
7.4 Barbados 210
7.5 Bermuda 211
7.6 Canada 212
7.7 Cuba 214
7.8 Dominica 215
7.9 Dominican Republic 216
7.10 Greenland 217
7.11 Grenada 218
7.12 Haiti 218
7.13 Jamaica 219
7.14 Puerto Rico 220
7.15 St. Kitts and Nevis 221
7.16 St. Lucia 221
7.17 St. Vincent and the Grenadines 222
7.18 The Bahamas 223
7.19 The British Virgin Islands 223
7.20 The Cayman Islands 224
7.21 The U.S. Virgin Islands 225
7.22 The United States 225
7.23 Trinidad and Tobago 227
8 OCEANA 228
8.1 Executive Summary 228
8.2 American Samoa 229
8.3 Australia 230
8.4 Christmas Island 231
8.5 Cook Islands 231
8.6 Fiji 232
8.7 French Polynesia 232
8.8 Guam 233
8.9 Kiribati 234
8.10 Marshall Islands 234
8.11 Micronesia Federation 235
8.12 Nauru 235
8.13 New Caledonia 236
8.14 New Zealand 237
8.15 Niue 238
8.16 Norfolk Island 238
8.17 Palau 239
8.18 Solomon Islands 239
8.19 The Northern Mariana Island 240
8.20 Tonga 241
8.21 Tuvalu 241
8.22 Vanuatu 242
8.23 Wallis and Futuna 242
8.24 Western Samoa 243
9 DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS 244
9.1 Disclaimers & Safe Harbor 244
9.2 ICON Group International, Inc. User Agreement Provisions 245

If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.